Navigation Links
FDA Approves Tradjenta™ (linagliptin) Tablets for the Treatment of Type 2 Diabetes
Date:5/2/2011

p>For more information, please visit http://us.boehringer-ingelheim.com and follow us on Twitter at http://twitter.com/boehringerus.

About Eli Lilly and Company

Lilly, a leading innovation-driven corporation, is developing a growing portfolio of pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, IN, Lilly provides answers – through medicines and information – for some of the world's most urgent medical needs. Additional information about Lilly is available at www.lilly.com.

About Lilly Diabetes

For more than 85 years, Lilly has been a worldwide leader in pioneering industry-leading solutions to support people living with and treating diabetes. Lilly introduced the world's first commercial insulin in 1923, and remains at the forefront of medical and delivery device innovation to manage diabetes. Lilly is also committed to providing solutions beyond therapy – practical tools, education, and support programs to help overcome barriers to success along the diabetes journey. At Lilly, the journeys of each person living with or treating diabetes inspire ours. For more information, visit www.lillydiabetes.com.

This press release contains forward-looking statements about Tradjenta™ (linagliptin) tablets for the treatment of type 2 diabetes. It reflects Lilly's current beliefs; however, as with any such undertaking, there are substantial risks and uncertainties in the process of drug development and commercialization. There is no guarantee that future study results and patient experience will be consistent with study findings to date or that TRADJENTA will be commercially successful. Fo
'/>"/>

SOURCE Boehringer Ingelheim Pharmaceuticals, Inc.; Eli Lilly and Company
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. FDA Approves Lillys Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women
2. Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV
3. FDA Approves Cymbalta(R) for Maintenance Treatment of Major Depressive Disorder
4. European Commission Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for Virologically Suppressed Adults With HIV-1 Infection
5. FDA Approves MiddleBrooks Amoxicillin PULSYS for Pharyngitis/Tonsillitis in Adolescents and Adults
6. FDA Approves XYZAL(R) (levocetirizine dihydrochloride) Oral Solution for the Relief of Seasonal and Year Round Allergies and Chronic Idiopathic Urticaria
7. UM Maryland Industrial Partnerships Program Approves 18 Collaborative Research Projects, Worth $4.4 Million, Between University Faculty, State Technology Companies
8. U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for the Acute Treatment of Manic and Mixed Episodes Associated With Bipolar I Disorder in Pediatric Patients (10 to 17 Years of Age)
9. U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older
10. FDA Approves HIFU Clinical Trial for Recurrent Prostate Cancer
11. EPA Approves XDS-CALUX(R) as Alternate Dioxin Test Method 4435
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... Minn. , June 30, 2015  EnteroMedics Inc. ... devices that use neuroblocking technology to treat obesity, metabolic ... its previously announced public offering  of 40,229,886 units. Each ... of a Series A warrant to purchase one share ... warrant to purchase one share of common stock, at ...
(Date:6/30/2015)... June 30, 2015  Isis Pharmaceuticals, Inc. (NASDAQ: ... 2015 Annual Meeting of StockholdersWhen:Tuesday, June 30 at 5:10 ... the Internet.  Simply log onto our website listed above. ... during the live event, a replay of the webcast ... www.isispharm.com . ABOUT ISIS PHARMACEUTICALS, INC. ...
(Date:6/29/2015)... , June 29, 2015  Daktari Diagnostics was honored ... the Technology in the Service of Society Award. IEEE President ... Barry L. Shoop presented the award to Principal ... The ceremony was held Saturday, June 20, 2015, at the ... . "I have spent more than ...
Breaking Medicine Technology:EnteroMedics Inc. Announces Pricing of $35.0 Million Public Offering of Common Stock and Warrants 2EnteroMedics Inc. Announces Pricing of $35.0 Million Public Offering of Common Stock and Warrants 3Webcast Alert: Corporate Presentation at the 2015 Isis Pharmaceuticals Annual Stockholder Meeting 2Webcast Alert: Corporate Presentation at the 2015 Isis Pharmaceuticals Annual Stockholder Meeting 3Daktari Honored with IEEE Spectrum Award 2
... leading provider of medical scrubs, is now accepting nominations through ... . The award provides the nation an opportunity to recognize ... duty to make a difference for their patients and the ... 9,000 healthcare professionals have been nominated for the award. To ...
... 2011 Wako Diagnostics, a division of Wako Chemicals ... and Drug Administration (FDA) to market the uTASWako i30 ... in vitro diagnostic (IVD) tests in the ... use by healthcare professionals as an aid in the ...
Cached Medicine Technology:Cherokee Inspired Comfort Award Calls for Healthcare Professional Nominations 2Cherokee Inspired Comfort Award Calls for Healthcare Professional Nominations 3Announcing 510(k) Clearance of a New Microfluidic-based IVD Test System, the uTASWako® i30 Immunoanalyzer, and AFP-L3 and DCP Assays for Liver Cancer Risk Assessment. 2
(Date:6/30/2015)... EAGAN, Minn. (PRWEB) , ... June 30, 2015 , ... ... $1.5 million in funding for 24 projects across the state. The projects improve community ... Grants range from $25,000 to $100,000 and many are renewable for a second year ...
(Date:6/30/2015)... Ohio (PRWEB) , ... June 30, 2015 , ... ... services nationwide, is pleased to announce it’s own Debby Mann, CPC, RCC, ROCC, ... Association (RBMA) Radiology Summit with the Special Recognition Award for her contribution to ...
(Date:6/30/2015)... ... 30, 2015 , ... The LIV Fertility Center in Puerto Vallarta ... right age to pursue egg freezing. Statistics show that 20 percent of women are ... 150 percent increase since the 1970s. , Sadly, for women who have delayed parenthood ...
(Date:6/30/2015)... ... June 30, 2015 , ... The American Lung Association in ... media event in San Diego. Speakers and clean air advocates included San Diego County ... Germuska of Kindred Hospital, and Daniel Sullivan, founder and president of Sullivan Solar Power. ...
(Date:6/30/2015)... (PRWEB) , ... June 30, 2015 , ... ... nationwide, announces today that they have been awarded the exclusive billing agreements with ... full range of billing services encompassing their proprietary suite of billing process software ...
Breaking Medicine News(10 mins):Health News:Blue Cross and Blue Shield of Minnesota Foundation Awards $1.5 Million 2Health News:ADVOCATE’s Debby Mann Honored With Special Recognition Award 2Health News:LIV Fertility Center Educating Women on the Critical Timing of Egg Freezing 2Health News:LIV Fertility Center Educating Women on the Critical Timing of Egg Freezing 3Health News:LIV Fertility Center Educating Women on the Critical Timing of Egg Freezing 4Health News:LIV Fertility Center Educating Women on the Critical Timing of Egg Freezing 5Health News:Local Dignitaries Gather to Announce San Diego’s Clean Air Challenge 2Health News:Local Dignitaries Gather to Announce San Diego’s Clean Air Challenge 3Health News:ADVOCATE Wins Billing Agreements with Jackson Radiology Associates 2
... , , , ... Los Angeles today announced that Caroline W. Nahas, managing director of ... the new volunteer chair of the organization,s corporate board of directors. ... served in this important role. Nahas will replace outgoing board chair, ...
... four sites across the country to participate in a new ... the effectiveness of a chemotherapeutic agent, ThermoDox, used in conjunction ... recurrent chest wall breast cancer. Recurrent chest wall ... the chest wall, most commonly presenting in the skin overlying ...
... ... tips on keeping kids healthy and active this summer , ... Minneapolis, MN (PRWEB) July 20, 2009 -- On soccer fields ... enjoy the summer sun. While the occasional bump or bruise is expected and normal, some ...
... , NAPERVILLE, Ill., July 20 The ... that Maryjane A. Wurth, 53, Chief Operating Officer, Healthcare Association of ... of IHA. Wurth succeeds Ken Robbins, who has served as IHA ... assume her duties as IHA,s president in October. , ...
... to view smoking-related content, study shows, , MONDAY, July 20 ... isn,t watching TV shows or movies that glamorize smoking, he ... the Internet, particularly from popular social networking sites such as ... 20 in Pediatrics , found that the Internet is ...
... , CAMP HILL, Pa., July 20 Highmark Blue Shield ... Health Conference, set for Saturday, Aug. 29 from 6:30 a.m. until 3 ... and University Drive in Hershey, Pa. , , ... a greater hand in their health by attending Fun, Fit & Fabulous! ...
Cached Medicine News:Health News:Caroline W. Nahas Named New Corporate Board Chair for United Way of Greater Los Angeles 2Health News:Caroline W. Nahas Named New Corporate Board Chair for United Way of Greater Los Angeles 3Health News:RI Hospital first in country to enroll patient in new study for recurrent chest wall breast cancer 2Health News:Treating Kids' Summertime Bumps, Bruises and Injuries with The Healthcare Scoop 2Health News:Treating Kids' Summertime Bumps, Bruises and Injuries with The Healthcare Scoop 3Health News:Maryjane A. Wurth Named New President of Illinois Hospital Association 2Health News:Internet May Be Newest Venue for Teen Tobacco Exposure 2Health News:Internet May Be Newest Venue for Teen Tobacco Exposure 3Health News:Feel Fun, Fit & Fabulous! At the 2009 Women's Health Conference 2Health News:Feel Fun, Fit & Fabulous! At the 2009 Women's Health Conference 3
The URCA (Uric acid) method used on the Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of uric acid in serum, plasma and urine....
For the quantitative in vitro determination of apolipoprotein A-1 (apo A-1) in serum and plasma. For use as an aid if assessing the risk of coronary artery disease....
The GGT method used on the Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of g-glutamyl transferase activity in serum and plasma...
For the quantitative in vitro determination of Triglycerides in serum and plasma....
Medicine Products: